For Immediate Release
SAN DIEGO, Calif. – November 30, 2022 – Cushman & Wakefield announced the firm has brokered the sale of a freestanding office/medical project of 26,945 square feet in Escondido (San Diego), California. Located at 800 W Valley Pkwy, the two-story property sold for $8.1 million to an owner/occupier.
The buyer was The Elizabeth Hospice, which for more than 40 years has been providing medical care and grief support to patients and families dealing with the challenges associated with an advanced, life-limiting illness. The buyer will initially occupy 80% of the building with plans to occupy the entire building as the existing tenants vacate.
Peter Curry and Mark Avilla with Cushman & Wakefield’s Private Capital Group together with Bob Cowan and Matty Sundberg also of the firm represented the seller, a private local investor, in the transaction. Don Zech, Nick Zech and Matt Orth of CDC Commercial represented the buyer.
Senior Director Mark Avilla said, “This is a beautiful, high image building with modern interior and exterior design that provides a nice and comforting environment. The location is also easily accessible near Interstate-15 and State Route 78, while there are a variety of amenities surrounding the property.”
About Cushman & Wakefield
Cushman & Wakefield (NYSE: CWK) is a leading global real estate services firm that delivers exceptional value for real estate occupiers and owners. Cushman & Wakefield is among the largest real estate services firms with approximately 50,000 employees in over 400 offices and approximately 60 countries. In 2021, the firm had revenue of $9.4 billion across core services of property, facilities and project management, leasing, capital markets, and valuation and other services. To learn more, visit www.cushmanwakefield.com or follow @CushWake on Twitter.
Media Contact:
Joshua Deale
Cushman & Wakefield
Communications Manager, West Region
+1 415 677 0423
joshua.deale@cushwake.com
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
